Literature DB >> 21578251

(E)-Ethyl 3-(3-bromo-phen-yl)-2-cyano-acrylate.

Yin Ye1, Wei-Li Shen, Xian-Wen Wei.   

Abstract

The title mol-ecule, C(12)H(10)BrNO(2), adopts an E configuration with respect to the C=C bond of the acrylate unit. In the crystal structure, mol-ecules are connected by a pair of inter-molecular C-H⋯O hydrogen bonds, forming a centrosymmetric dimer.

Entities:  

Year:  2009        PMID: 21578251      PMCID: PMC2971297          DOI: 10.1107/S1600536809039518

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the synthesis, see: Lapworth & Baker (1927 ▶). For the title compound as an inter­mediate in drug synthesis, see: Obniska et al. (2005 ▶).

Experimental

Crystal data

C12H10BrNO2 M = 280.12 Monoclinic, a = 7.6147 (7) Å b = 21.6015 (19) Å c = 7.6044 (7) Å β = 110.370 (1)° V = 1172.62 (18) Å3 Z = 4 Mo Kα radiation μ = 3.49 mm−1 T = 298 K 0.17 × 0.14 × 0.09 mm

Data collection

Bruker SMART APEX CCD area-detector diffractometer Absorption correction: multi-scan (; Sheldrick, 1996 ▶) T min = 0.597, T max = 0.751 10143 measured reflections 2698 independent reflections 1730 reflections with I > 2σ(I) R int = 0.038

Refinement

R[F 2 > 2σ(F 2)] = 0.034 wR(F 2) = 0.081 S = 1.00 2698 reflections 146 parameters H-atom parameters constrained Δρmax = 0.21 e Å−3 Δρmin = −0.33 e Å−3 Data collection: SMART (Bruker, 2000 ▶); cell refinement: SAINT (Bruker, 2000 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL. Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536809039518/is2461sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536809039518/is2461Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C12H10BrNO2F(000) = 560
Mr = 280.12Dx = 1.587 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 2803 reflections
a = 7.6147 (7) Åθ = 2.9–25.8°
b = 21.6015 (19) ŵ = 3.49 mm1
c = 7.6044 (7) ÅT = 298 K
β = 110.370 (1)°Block, colorless
V = 1172.62 (18) Å30.17 × 0.14 × 0.09 mm
Z = 4
Bruker SMART APEX CCD area-detector diffractometer2698 independent reflections
Radiation source: fine-focus sealed tube1730 reflections with I > 2σ(I)
graphiteRint = 0.038
φ and ω scansθmax = 27.6°, θmin = 1.9°
Absorption correction: multi-scan (SADABS; Sheldrick, 1996)h = −9→9
Tmin = 0.597, Tmax = 0.751k = −28→28
10143 measured reflectionsl = −8→9
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.034Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.081H-atom parameters constrained
S = 1.00w = 1/[σ2(Fo2) + (0.0337P)2 + 0.2149P] where P = (Fo2 + 2Fc2)/3
2698 reflections(Δ/σ)max = 0.001
146 parametersΔρmax = 0.21 e Å3
0 restraintsΔρmin = −0.33 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Br11.32627 (4)0.459872 (14)0.80815 (5)0.06743 (14)
C51.1401 (4)0.40161 (12)0.6781 (4)0.0491 (7)
C60.9564 (4)0.42010 (12)0.6053 (4)0.0464 (6)
H60.92400.46080.61930.056*
C70.6257 (4)0.39971 (12)0.4366 (4)0.0481 (6)
H70.60600.43730.48620.058*
C10.8179 (3)0.37725 (11)0.5098 (4)0.0460 (6)
N10.4728 (3)0.27353 (12)0.1299 (4)0.0694 (7)
C80.4721 (3)0.37490 (11)0.3089 (3)0.0438 (6)
C41.1939 (4)0.34169 (14)0.6612 (4)0.0626 (8)
H41.31920.33010.71010.075*
C20.8709 (4)0.31640 (13)0.4958 (4)0.0629 (8)
H20.78060.28700.43620.075*
C10−0.0327 (4)0.40634 (13)0.0878 (4)0.0579 (8)
H10A−0.03600.44040.00350.069*
H10B−0.05780.42250.19570.069*
C11−0.1756 (4)0.35851 (14)−0.0101 (5)0.0682 (9)
H11A−0.14520.3412−0.11220.102*
H11B−0.29720.3774−0.05770.102*
H11C−0.17590.32630.07680.102*
C31.0573 (4)0.29951 (14)0.5701 (5)0.0754 (10)
H31.09120.25880.55820.090*
O20.1493 (2)0.37612 (8)0.1469 (2)0.0517 (5)
O10.2787 (3)0.46073 (9)0.3104 (3)0.0703 (6)
C120.4724 (3)0.31789 (13)0.2110 (4)0.0500 (7)
C90.2926 (4)0.40931 (13)0.2581 (4)0.0493 (7)
U11U22U33U12U13U23
Br10.04546 (19)0.0595 (2)0.0794 (2)−0.00844 (14)−0.00088 (15)−0.00303 (16)
C50.0422 (15)0.0497 (16)0.0478 (16)−0.0039 (12)0.0061 (13)0.0000 (12)
C60.0477 (16)0.0381 (14)0.0488 (16)0.0000 (11)0.0109 (12)0.0000 (12)
C70.0445 (15)0.0409 (14)0.0548 (17)−0.0001 (11)0.0119 (13)−0.0013 (12)
C10.0394 (14)0.0436 (14)0.0476 (16)−0.0031 (11)0.0058 (12)0.0004 (12)
N10.0519 (15)0.0609 (16)0.092 (2)−0.0110 (12)0.0204 (14)−0.0237 (15)
C80.0381 (14)0.0438 (14)0.0474 (16)−0.0023 (11)0.0123 (12)−0.0003 (12)
C40.0421 (16)0.0558 (17)0.076 (2)0.0073 (13)0.0024 (15)−0.0037 (15)
C20.0503 (17)0.0469 (16)0.074 (2)−0.0019 (13)−0.0010 (15)−0.0078 (14)
C100.0349 (15)0.0605 (18)0.073 (2)0.0057 (13)0.0125 (14)−0.0015 (15)
C110.0390 (16)0.077 (2)0.079 (2)−0.0025 (15)0.0092 (15)0.0018 (17)
C30.0539 (19)0.0490 (17)0.102 (3)0.0099 (14)0.0000 (18)−0.0102 (17)
O20.0350 (10)0.0511 (11)0.0634 (12)−0.0005 (8)0.0098 (9)−0.0070 (9)
O10.0505 (12)0.0600 (13)0.0904 (16)0.0028 (10)0.0119 (11)−0.0251 (11)
C120.0329 (14)0.0529 (16)0.0594 (18)−0.0069 (12)0.0098 (13)−0.0009 (14)
C90.0410 (15)0.0534 (17)0.0505 (17)−0.0041 (12)0.0120 (13)−0.0033 (13)
Br1—C51.896 (2)C4—H40.9300
C5—C61.372 (3)C2—C31.382 (4)
C5—C41.377 (4)C2—H20.9300
C6—C11.401 (3)C10—O21.454 (3)
C6—H60.9300C10—C111.497 (4)
C7—C81.344 (3)C10—H10A0.9700
C7—C11.456 (3)C10—H10B0.9700
C7—H70.9300C11—H11A0.9600
C1—C21.390 (4)C11—H11B0.9600
N1—C121.140 (3)C11—H11C0.9600
C8—C121.439 (4)C3—H30.9300
C8—C91.484 (4)O2—C91.333 (3)
C4—C31.374 (4)O1—C91.197 (3)
C6—C5—C4122.0 (2)O2—C10—C11107.1 (2)
C6—C5—Br1119.3 (2)O2—C10—H10A110.3
C4—C5—Br1118.7 (2)C11—C10—H10A110.3
C5—C6—C1119.6 (2)O2—C10—H10B110.3
C5—C6—H6120.2C11—C10—H10B110.3
C1—C6—H6120.2H10A—C10—H10B108.6
C8—C7—C1130.5 (2)C10—C11—H11A109.5
C8—C7—H7114.8C10—C11—H11B109.5
C1—C7—H7114.8H11A—C11—H11B109.5
C2—C1—C6118.6 (2)C10—C11—H11C109.5
C2—C1—C7124.5 (2)H11A—C11—H11C109.5
C6—C1—C7116.9 (2)H11B—C11—H11C109.5
C7—C8—C12123.9 (2)C4—C3—C2121.3 (3)
C7—C8—C9118.6 (2)C4—C3—H3119.3
C12—C8—C9117.5 (2)C2—C3—H3119.3
C3—C4—C5118.2 (3)C9—O2—C10115.9 (2)
C3—C4—H4120.9N1—C12—C8178.3 (3)
C5—C4—H4120.9O1—C9—O2124.2 (3)
C3—C2—C1120.2 (3)O1—C9—C8124.0 (2)
C3—C2—H2119.9O2—C9—C8111.8 (2)
C1—C2—H2119.9
C4—C5—C6—C1−0.3 (4)C7—C1—C2—C3−179.9 (3)
Br1—C5—C6—C1−179.72 (19)C5—C4—C3—C20.5 (5)
C5—C6—C1—C21.6 (4)C1—C2—C3—C40.9 (5)
C5—C6—C1—C7179.8 (2)C11—C10—O2—C9−171.7 (2)
C8—C7—C1—C2−17.9 (5)C10—O2—C9—O10.5 (4)
C8—C7—C1—C6164.1 (3)C10—O2—C9—C8−179.3 (2)
C1—C7—C8—C12−1.8 (5)C7—C8—C9—O17.3 (4)
C1—C7—C8—C9−178.8 (3)C12—C8—C9—O1−169.9 (3)
C6—C5—C4—C3−0.8 (5)C7—C8—C9—O2−172.8 (2)
Br1—C5—C4—C3178.7 (2)C12—C8—C9—O29.9 (3)
C6—C1—C2—C3−1.9 (5)
D—H···AD—HH···AD···AD—H···A
C6—H6···O1i0.932.473.323 (3)152
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
C6—H6⋯O1i0.932.473.323 (3)152

Symmetry code: (i) .

  2 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Anticonvulsant properties of N-(4-methylpiperazin-1-yl)- and N-[3-(4-methyl-piperazin-1-yl)propyl] derivatives of 3-aryl- and 3-spirocycloalkyl-pyrrolidine-2,5-dione.

Authors:  Jolanta Obniska; Sławomir Jurczyk; Alfred Zejc; Krzysztof Kamiński; Ewa Tatarczyńska; Katarzyna Stachowicz
Journal:  Pharmacol Rep       Date:  2005 Mar-Apr       Impact factor: 3.024

  2 in total
  5 in total

1.  (E)-Ethyl 2-cyano-3-(furan-2-yl)acrylate.

Authors:  Rajesh G Kalkhambkar; D Gayathri; Vivek K Gupta; Rajni Kant; Yeon Tae Jeong
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-04-21

2.  (E)-Ethyl 2-cyano-3-(1H-pyrrol-2-yl)acrylate.

Authors:  Haldorai Yuvaraj; D Gayathri; Rajesh G Kalkhambkar; Vivek K Gupta
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-07-23

3.  (E)-2-[(2-Formyl-phen-oxy)meth-yl]-3-(4-iso-propyl-phen-yl)acrylo-nitrile.

Authors:  J Kanchanadevi; G Anbalagan; R Selvakumar; M Bakthadoss; B Gunasekaran; V Manivannan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-07-31

4.  8-Bromo-3-(4-ethyl-phen-yl)-1-phenyl-3,3a,4,9b-tetra-hydro-1H-chromeno[4,3-c]isoxazole-3a-carbo-nitrile.

Authors:  J Kanchanadevi; G Anbalagan; J Srinivasan; M Bakthadoss; B Gunasekaran; V Manivannan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-09-12

5.  (E)-2-Bromo-methyl-3-(o-tol-yl)acrylo-nitrile.

Authors:  J Kanchanadevi; G Anbalagan; R Selvakumar; M Bakthadoss; B Gunasekaran; V Manivannan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-08-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.